Mirzaten

Medicinal product

(Invented) name

Mirzaten

Active substance (s)

Mirtazapinas

Strength

15 mg

Pharmaceutical form

burnoje disperguojamos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06AX11, Mirtazapine

Marketing authorisation holder

KRKA, d.d., Novo mesto, Slovėnija

Date of authorisation

2008-02-08

Date of renewal

2013-06-20

Documents

1004 Pakuotės lapelis disperg 2021 12 22.docx

1004 Mirzaten disperg tab RPP 2021 12 22.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Mirtazapinas	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
18990	4839	1004839	lizdinė plokštelė	N30		Receptinis	LT/1/04/1004/001	Netiekiama	-	-	No	-	-	Download
18991	22467	1022467	lizdinė plokštelė	N60		Receptinis	LT/1/04/1004/002	Netiekiama	-	-	No	-	-
18992	22468	1022468	lizdinė plokštelė	N90		Receptinis	LT/1/04/1004/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2013-06-20	Perregistruotas
2008-02-08	Registruotas